University of Texas-Arlington Scientists Part of $11M Study of Precision Therapy for Heart Failure Patients With Preserved Ejection Fraction
July 22, 2019
July 22, 2019
ARLINGTON, Texas, July 22 -- The University of Texas's Arlington Campus issued the following news release:
Nearly half of all heart failure patients do not have effective treatments for their condition, so three researchers at The University of Texas at Arlington are taking a more precise approach.
Mark Haykowksy, Michael Nelson and Paul Fadel, faculty members in the College of Nursing and Health Innovation, are part of an $11 million project funded by the National Inst . . .
Nearly half of all heart failure patients do not have effective treatments for their condition, so three researchers at The University of Texas at Arlington are taking a more precise approach.
Mark Haykowksy, Michael Nelson and Paul Fadel, faculty members in the College of Nursing and Health Innovation, are part of an $11 million project funded by the National Inst . . .